Samsher Singh

6PUBLICATIONS
34CO-AUTHORS
BacteriologyMedical bacteriologyMedical infection agents (incl. prions)Medical molecular engineering of nucleic acids and proteinsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 06, 2026
A bactericidal tuberculosis drug regimen driven by inhibition of the terminal oxidases by pretomanid.

Nurlilah Ab Rahman, Samsher Singh, Thomas Wiggins

|Dec 01, 2025
A Mycobacteria-Specific Prodrug to Overcome Phenotypic AMR in Mycobacterium tuberculosis.

T Anand Kumar, Shalini Birua, Sharath Chandra Mallojjala

|Nov 24, 2025
A bioluminescence-based chemical screen identifies a bactericidal naphthalene scaffold targeting MmpL3 in Mycobacterium abscessus.

Samsher Singh, Ria Sorayah, Yushu Chen

|Nov 20, 2023
GaMF1.39's antibiotic efficacy and its enhanced antitubercular activity in combination with clofazimine, Telacebec, ND-011992, or TBAJ-876.

Priya Ragunathan, Pearly Shuyi Ng, Samsher Singh

|Aug 17, 2022
Moxifloxacin-Mediated Killing of Mycobacterium tuberculosis Involves Respiratory Downshift, Reductive Stress, and Accumulation of Reactive Oxygen Species.

Somnath Shee, Samsher Singh, Ashutosh Tripathi

|Jan 04, 2022
Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition.

Mousumi Shyam, Harshita Verma, Gourab Bhattacharje

Pageof 1

Frequent Collaborators

3 joint publications

Amit Singh

2 joint publications

Kevin Pethe

2 joint publications

Piyali Mukherjee

2 joint publications

Marvin J Miller